Earnings History Data for AVROBIO, Inc. (AVRO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AVROBIO, Inc.
Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11-05-2023 | PM | AVRO | AVROBIO | 31.00 | -0.57 | -0.56 | 0.00 | AVROBIO GAAP EPS of -$0.57 misses by $0.01 [5/11/2023 9:49 AM] |
0.68 | 0.01 (1.19%) |
0.0 | 0.0 (0.00%) |
0.56 - 1.93 | 283,384 | 550,000 | 0 | ||
08-11-2022 | PM | AVRO | AVROBIO | 29.00 | -0.52 | -0.50 | 0.00 | AVROBIO GAAP EPS of -$0.52 beats by $0.01 [11/8/2022 9:00 AM] |
0.6549 | 0.0 (-0.76%) |
0.0 | 0.0 (0.00%) |
0.56 - 6.20 | 342,995 | 200,000 | 0 | ||
09-08-2022 | PM | AVRO | AVROBIO | 43.00 | -0.64 | -0.54 | 0.00 | AVROBIO GAAP EPS of -$0.64 misses by $0.09 [8/9/2022 8:31 AM] |
1.01 | 0.01 (0.50%) |
0.0 | 0.0 (0.00%) |
0.74 - 7.77 | 329,330 | 230,000 | 0 | ||
10-05-2022 | PM | AVRO | AVROBIO | 36.00 | -0.68 | -0.58 | 0.00 | AVROBIO GAAP EPS of -$0.68 misses by $0.11 [5/10/2022 7:41 AM] |
0.84 | 0.02 (2.18%) |
0.84 | 0.02 (1.97%) |
0.78 - 11.00 | 163,809 | 446,890 | 2,691 | ||
13-05-2021 | PM | AVRO | AVROBIO, Inc. | 354.18 | -0.65 | -0.77 | -0.77 | AVROBIO reports Q1 results [5/13/2021 8:06 AM] |
8.79 | 0.0 (0.00%) |
8.79 | 0.0 (0.00%) |
7.45 - 23.50 | 489,294 | 600,000 | 3,447 | ||
18-03-2021 | PM | 7:00 AM ET (Mar 18) |
AVRO | Avrobio, Inc. | 494.00 | -0.73 | -0.87 | 0.00 | AVROBIO EPS beats by $0.17 [3/18/2021 7:43 AM] |
12.82 | -0.88 (-6.42%) |
13.70 | 0.0 (0.00%) |
9.86 - 23.50 | 450,973 | 790,000 | 2,917 | |
05-11-2020 | PM | AVRO | AVROBIO, Inc. | 565.22 | -1.01 | -0.81 | -0.57 | AVROBIO EPS misses by $0.19 [11/5/2020 7:29 AM] |
14.91 | -1.75 (-10.50%) |
14.91 | 0.0 (0.00%) |
9.76 - 29.32 | 173,364 | 181,153 | 293 | ||
|